Previous 10 | Next 10 |
Halozyme Therapeutics, Inc. (HALO) Q1 2022 Earnings Conference Call May 10, 2022 04:30 PM ET Company Participants Helen Torley - President & Chief Executive Officer Nicole LaBrosse - Chief Financial Officer Conference Call Participants Charles Duncan - Cantor Fitzgerald Mike DiFiore - Eve...
The following slide deck was published by Halozyme Therapeutics, Inc. in conjunction with their 2022 Q1 earnings call. For further details see: Halozyme Therapeutics, Inc. 2022 Q1 - Results - Earnings Call Presentation
Halozyme Therapeutics press release (NASDAQ:HALO): Q1 Non-GAAP EPS of $0.47 misses by $0.02. Revenue of $117.3M (+31.8% Y/Y) misses by $10.95M. Shares +0.68%. For further details see: Halozyme Therapeutics Non-GAAP EPS of $0.47 misses by $0.02, revenue of $117.3M misses by $10.95M
Halozyme Reports First Quarter 2022 Results PR Newswire First Quarter Revenue of $117.3 million , Representing a 32% YOY Increase, with GAAP Diluted Earnings per Share of $0.43 and Non-GAAP Diluted Earnings per Share of $0.47 Record Quarterly Royalt...
Halozyme To Host First Quarter 2022 Financial Results Webcast and Conference Call PR Newswire SAN DIEGO , May 3, 2022 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) will webcast its Quarterly Update Conference Call for the first quarter 2022 o...
Value investing consists of buying unappreciated or ignored stocks at attractive prices. Value investing avoids the current stock market darlings. Lakonishok created a stir in the finance community through his research in behavioral finance. For further details see: Find...
Bernzott Capital Advisors are independent money managers for institutional, intermediary and private clients. Our investment philosophy is fundamentally based and time tested. Equity markets fell globally, and bonds posted their worst quarterly return in over 40 years. The portfol...
HALOZYME COMMENCES TENDER OFFER FOR ALL OUTSTANDING SHARES OF COMMON STOCK OF ANTARES PHARMA PR Newswire SAN DIEGO , April 26, 2022 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced that it is commencing, th...
Thoma Bravo continued its binge of software acquisitions last week by entering into an agreement to acquire SailPoint Technologies. Kaseya, a provider of unified IT management and security software, entered into a definitive agreement to acquire Datto Holdings for $6.2 billion. Wi...
5 Top Biotech Stocks To Watch Today The stock market offers plenty of opportunities for investors. Some industries would still catch the attention of investors regardless of the broader market sentiment. A prime example would be biotech stocks . Now, why is that so? For starters...
News, Short Squeeze, Breakout and More Instantly...
Halozyme Therapeutics Inc. Company Name:
HALO Stock Symbol:
NASDAQ Market:
Halozyme Therapeutics Inc. Website:
Halozyme to Report Second Quarter 2024 Financial and Operating Results PR Newswire SAN DIEGO , July 23, 2024 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced it will release its second quarter 2024 financial and operating re...
2024-07-22 03:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...